A team of researchers from Cleveland Clinic Genomic Medicine share insights from an early set of 19,000 patients to receive immune checkpoint inhibitor treatments for colorectal cancer in the U.S.

Adding an immune checkpoint inhibitor (ICI) to chemotherapy for advanced prostate cancer failed to improve survival as ...

Clinical characteristics were associated with different survival outcomes in patients treated with immune checkpoint ...

Patients receiving ICIs were associated with a greater risk of developing RA, but lower risks for SLE and SSc.

Antitumor activity observed with confirmed partial responses in 50% of patientsat highest dose tested to date, across ...

In this article, explore how the research into blocking these checkpoints has led to immune checkpoint inhibitors (ICIs), a promising but still evolving class of immunotherapy that falls under the ...

An expert discusses how the availability of subcutaneous (SC) immune checkpoint inhibitors (ICI) for bladder cancer impacts ...

Glioblastoma has long resisted treatment, but scientists may have found a breakthrough by leveraging the body's own ...

Australia: Researchers have found in a small study that immune checkpoint inhibitors (ICIs) used for cancer treatment ...

The Data Safety Monitoring Board (DSMB) identified no safety concerns, and recommended continuation of BriaCell’s pivotal Phase 3 study of ...

Glioblastoma has remained one of the toughest cancers to treat, resisting even the latest advances in immunotherapy. But new ...

An expert discusses how medical professionals counsel eligible patients about adjuvant immune checkpoint inhibitor (ICI) ...